Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | UTHR | Common Stock | Options Exercise | $0 | +3.36K | +58.03% | $0.00 | 9.15K | Jun 26, 2021 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | UTHR | Restricted Stock Units | Options Exercise | $0 | -3.36K | -100% | $0.00* | 0 | Jun 26, 2021 | Common Stock | 3.36K | $0.00 | Direct | F2, F3 |
Id | Content |
---|---|
F1 | Shares received upon vesting of restricted stock units on June 26, 2021. Restricted stock units converted on a one-for-one basis into shares of common stock. |
F2 | Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. |
F3 | Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. |